Cover Image
市場調查報告書

脊髓刺激療法(SCS)的全球市場:產業分析與預測

Global Spinal Cord Stimulation Market: Industry Analysis & Outlook 2017-2021

出版商 Koncept Analytics 商品編碼 359254
出版日期 內容資訊 英文 69 Pages
訂單完成後即時交付
價格
Back to Top
脊髓刺激療法(SCS)的全球市場:產業分析與預測 Global Spinal Cord Stimulation Market: Industry Analysis & Outlook 2017-2021
出版日期: 2017年09月07日 內容資訊: 英文 69 Pages
簡介

本報告提供全球脊髓刺激療法(SCS) 市場相關美國為中心的調查,治療方法概要、機制,患者人口,主要的市場趨勢及市場成長的各種影響因素分析,美國及美國以外地區的市場規模的變化與預測,競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 市場概要

  • 簡介
  • 脊髓刺激設備
  • 電刺激治療的條件
  • 電刺激療法
  • 外科手術

第2章 全球脊髓刺激療法(SCS)市場

  • 全球SCS市場預測:以金額為準
  • 全球SCS市場:各地區
  • 全球SCS目標人口的預測
  • 全球SCS系統移植治療數量的預測

第3章 地區的脊髓刺激療法(SCS)市場

  • 美國
    • 慢性腰痛的盛行率的預測
    • 美國的SCS市場預測:以金額為準
    • 美國的SCS目標人口的預測
    • 美國的SCS系統移植治療數量的預測
  • 美國以外
    • 美國以外的SCS市場預測:以金額為準
    • 美國以外的SCS目標人口的預測
    • 美國以外的SCS系統移植治療數量的預測
    • 美國以外的充電式SCS市場預測:以金額為準

第4章 市場動態

  • 成長推動因素
  • 主要的發展趨勢
  • 市場課題

第5章 競爭情形

  • 全球SCS市場
    • 收益及市值比較
    • 企業的市場佔有率
    • 主要SCS產品比較:各企業
  • 地區的SCS市場
    • 美國的SCS市場佔有率
    • 美國以外的SCS市場佔有率

第6章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Spinal cord stimulation (SCS) is a therapy for people who are not relieved from back or neck pain by surgeries and other treatments. It helps to treat pain by hiding pain signals before reaching brain. A device is implanted in body to deliver the signals to spinal cord. Battery attached to pulse generator are of two types, non-rechargeable and rechargeable batteries for the power demand of device.

Failed back surgery is the most common reason for spinal cord stimulation surgery. SCS is a two step process to determine whether spinal cord stimulation will work for the patients or not. Trial spinal cord stimulation is a test drive to determine if therapy will provide pain relief to the patient or not. After the implantation in trial, patient considers the permanent implantation of device based on pain relief improvement.

The U.S. is the main contributor to the SCS market with increasing chronic back pain prevalence and rising addressable population for SCS. The U.S. has great potential in the years ahead with favorable reimbursement policies and improved health service quality. The growth of SCS outside the U.S. is driven by increasing awareness and need for new therapies and devices. The market is relatively small due to lack of reimbursements, that limits the growth of the market.

The global SCS market is expected to grow in future due to growing ageing population, increase in health care expenditure and rising obese population. Key trends of this market include favorable reimbursement landscape in the U.S., launch of new products, awareness regarding early treatments, increase in trial SCS treatments, increasing demand for minimally invasive surgeries, increase SCS for predominant back pain and rising mergers & acquisitions activities. However, high cost of treatment, tough regulatory problems and dependency on traditional therapies are some of the factors posing challenge for the market growth.

The report "Global Spinal Cord Stimulation Market: Industry Analysis & Outlook (2017-2021)" by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S. and Outside the U.S. region. The report profiles the key players of the market including Nevro Corporation, Medtronic Plc., Abbott Laboratories (St. Jude) and Boston Scientific.

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Spinal Cord Stimulation Devices
  • 1.3 Conditions for SCS Treatment
  • 1.4 Spinal Cord Stimulation Therapies
  • 1.5 Surgical Procedures

2. Global Spinal Cord Stimulation (SCS) Market

  • 2.1 Global SCS Market Forecast by Value
  • 2.2 Global SCS Market by Region
  • 2.3 Global SCS Addressable Population Forecast
  • 2.4 Global SCS System Implant Volume Forecast

3. Regional Market

  • 3.1 The U.S.
    • 3.1.1 The U.S. Chronic Back Pain Prevalence Forecast
    • 3.1.2 The U.S. SCS Market Forecast by Value
    • 3.1.3 The U.S. Addressable SCS Population Forecast
    • 3.1.4 The U.S. SCS System Implant Volume Forecast
  • 3.2 Outside the U.S.
    • 3.2.1 Outside the U.S. SCS Market Forecast by Value
    • 3.2.2 Outside the U.S. SCS Addressable Population Forecast
    • 3.2.3 Outside the U.S. SCS System Implant Volume Forecast
    • 3.2.4 Outside the U.S. Rechargeable SCS Market Forecast by Value

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Rising Ageing Population
    • 4.1.2 Increasing Healthcare Spending
    • 4.1.3 Rising GDP Per Capita
    • 4.1.4 Increase in Obese Population
  • 4.2 Key Trends & Developments
    • 4.2.1 Increase in Trial Units for SCS in the U.S.
    • 4.2.2 Mergers and Acquisitions
    • 4.2.3 Increasing SCS Implants for Predominant Back Pain in the U.S.
    • 4.2.4 Accelerating Use of Percutaneous Lead Technology in SCS Treatments
    • 4.2.5 Increasing Demand for Minimally Invasive Devices
    • 4.2.6 Rising Awareness of Early Treatment for Chronic Pain
    • 4.2.7 New Product Launches
    • 4.2.8 Burden of Chronic Pain in the U.S.
    • 4.2.9 Favorable Reimbursement Policies in the U.S.
  • 4.3 Challenges
    • 4.3.1 Dependence on Traditional Therapies
    • 4.3.2 High Cost Related to SCS Treatment
    • 4.3.3 Tough Regulatory Problems

5. Competitive Landscape

  • 5.1 Global SCS Market
    • 5.1.1 Revenue and Market Cap Comparison
    • 5.1.2 Global SCS Market Share by Company
    • 5.1.3 Key SCS Product Comparison by Company
  • 5.2 Regional SCS Market
    • 5.2.1 The U.S. SCS Market Share by Company
    • 5.2.2 Outside the U.S. SCS Market Share by Company

6. Company Profiles

  • 6.1 Nevro Corporation
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 Medtronic Plc
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Boston Scientific
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 Abbott Laboratories (St. Jude Medical)
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies

List of Charts

  • Types of Electrical Stimulation For Chronic Pain
  • Global SCS Market Forecast by Value (2016-2021)
  • Global SCS Market by Region (2016)
  • Global SCS Addressable Population Forecast (2016-2021)
  • Global SCS System Implant Volume Forecast (2016-2021)
  • The U.S. Chronic Back Pain Prevalence Forecast (2016-2021)
  • The U.S. SCS Market Forecast by Value (2016-2021)
  • The U.S. Addressable SCS Population Forecast (2016-2021)
  • The U.S. SCS System Implant Volume Forecast (2016-2021)
  • OUS SCS Market Forecast by Value (2016-2021)
  • OUS SCS Addressable Population Forecast (2016-2021)
  • OUS SCS System Implant Volume Forecast (2016-2021)
  • OUS Rechargeable SCS Market Forecast by Value (2016-2021)
  • Global Ageing Population (2012-2016)
  • Global Healthcare Spending Per Capita (2012-2016)
  • Global GDP Per Capita (2012-2016)
  • Global Obese Population (2012-2016)
  • Increase Trial Units for SCS in the U.S. (2016-2021)
  • The U.S. SCS Implant Volume by Pain Location (2016)
  • The U.S. (2016)
  • Outside the U.S. (2016)
  • Global SCS Market Share by Company (2016/2020E)
  • The U.S. SCS Market Share by Company (2016)
  • Outside the U.S. SCS Market Share by Company (2016)
  • Nevro Corporation Revenue by Region (2016)
  • Nevro Corporation Revenue and Net Loss (2012-2016)
  • Nevro Corporation R&D Expenditure (2012-2016)
  • Medtronic Plc Revenue by Segment (2017*)
  • Medtronic Plc Net Revenue and Net Profit (2013-2017*)
  • Boston Scientific Revenue by Segment (2016)
  • Boston Scientific's Revenue and Annual Growth (2012-2016)
  • Abbott Laboratories Revenue by Segment (2016)
  • Abbott Laboratories Revenue and Net Income (2012-2016)
  • Abbott Laboratories R&D Expenditure (2012-2016)

List of Tables

  • Mergers and Acquisitions (2016-2017)
  • Key Players - Revenue & Market Cap Comparison (2016)
  • Key SCS Product Comparison by Company (2016)
Back to Top